Escalon Medical (ESMC) Stock Price, News & Analysis

Company Overview

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

Key Stats

• Today's Range: $0.39 to $0.39
• 50-Day Range: $0.26 to $0.46
• 52-Week Range: $0.11 to $0.46
• Volume: 803 shs
• Average Volume: 8,154 shs
• Market Capitalization: $2.89 million
• P/E Ratio: 7.80
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Escalon Medical Stock Analysis - MarketRank™

Escalon Medical scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Escalon Medical.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Escalon Medical is 7.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Escalon Medical is 7.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.10.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of Escalon Medical have been sold short.

Short Interest Ratio / Days to Cover

Escalon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Escalon Medical does not currently pay a dividend.

Dividend Growth

Escalon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of Escalon Medical have been sold short.

Short Interest Ratio / Days to Cover

Escalon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Escalon Medical this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Escalon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.90% of the stock of Escalon Medical is held by insiders.

ESMC Stock Analysis - Frequently Asked Questions

How have ESMC shares performed this year?

Escalon Medical's stock was trading at $0.1255 at the start of the year. Since then, ESMC stock has increased by 210.8% and is now trading at $0.39.

How were Escalon Medical's earnings last quarter?

Escalon Medical Corp. (OTCMKTS:ESMC) announced its earnings results on Wednesday, May, 14th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter. The medical equipment provider earned $3.47 million during the quarter. Escalon Medical had a net margin of 4.70% and a trailing twelve-month return on equity of 45.60%.

How do I buy shares of Escalon Medical?

Shares of ESMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Escalon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Escalon Medical investors own include XTI Aerospace (XTIA), Co-Diagnostics (CODX), Digital Ally Inc./NV (DGLY), Kopin (KOPN), Onconova Therapeutics (ONTX), Precipio (PRPO) and Tonix Pharmaceuticals (TNXP).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 8/10/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ESMC
• Previous Symbol: NASDAQ:ESMC
• CIK: 862668
• Web: www.escalonmedical.com
• Phone: (610) 688-6830
• Fax: 610-688-3641
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.05
• Trailing P/E Ratio: 7.80
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$130 thousand
• Net Margins: 4.70%
• Pretax Margin: 4.78%
• Return on Equity: 45.60%
• Return on Assets: 12.66%

Debt

• Debt-to-Equity Ratio: 0.14
• Current Ratio: 1.92
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $11.98 million
• Price / Sales: 0.24
• Cash Flow: $0.04 per share
• Price / Cash Flow: 10.82
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,415,000
• Free Float: 7,274,000
• Market Cap: $2.89 million
• Optionable: Not Optionable
• Beta: 0.43